Predictive modeling targets thymidylate synthase ThyX in Mycobacterium tuberculosis

Area of Science:

• Microbiology
• Medicinal Chemistry
• Drug Discovery

Background:

• Tuberculosis (TB) remains a significant global health threat, causing 1.5 million deaths annually.
• There is an urgent need for novel therapeutic strategies against Mycobacterium tuberculosis (Mtb).
• Naphthoquinones are a class of compounds with potential antibacterial activity.

Purpose of the Study:

• To identify new inhibitors of essential Mtb enzymes, ThyX and DNA gyrase.
• To explore structure-activity relationships for potential TB drug candidates.
• To discover novel treatments for tuberculosis.

Main Methods:

• Utilized cheminformatics and in vitro screening to identify inhibitors.
• Focused on two essential Mtb enzymes: ThyX (thymidylate synthase) and DNA gyrase.
• Evaluated whole-cell activity of identified compounds.

Main Results:

• Identified two novel Mtb ThyX inhibitors: 2-chloro-3-(4-methanesulfonylpiperazin-1-yl)-1,4-dihydronaphthalene-1,4-dione and idebenone.
• These compounds demonstrated modest whole-cell activity.
• Evidence suggests these inhibitors target Mtb ThyX.

Conclusions:

• The identified compounds represent promising leads for TB drug development.
• Targeting Mtb ThyX is a viable strategy for novel antibacterial therapies.
• Further research is warranted to optimize these inhibitors for clinical use.